 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | DAI Global LLC |
| Street 1: | 7600 Wisconsin Avenue |
| Street 2: | Suite 200 |
| City: | Bethesda, |
| Province: | Maryland |
| Post Code: | 20814 |
| Country: | United States of America |
| Phone: | 001 301 771 7600 |
| Organization Email: | bobby_jefferson@dai.com |
| Web Site: | http://www.dai.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Mission and Main focus : DAI is a global development company that works on the frontlines of international development, tackling fundamental social and economic development problems caused by inefficient markets, ineffective governance, and instability. Committed to shaping a more livable world. Why are you interested in TB: We implement projects within TB components and other health sectors around the world. What are you ding or planning to do for TB control : We are implementing projects with TB components and plan to continue doing so in future through implementing innovative solutions that support detection and treatment. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We are implementing innovative patent centered solutions in Haiti that manage patient level data, integrating HIV co-infected patients thereby improving quality of care for TB. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Albania Algeria Armenia Azerbaijan Bangladesh Bhutan Cambodia Central African Republic Chad Cote d'Ivoire Dominica El Salvador Eswatini Ethiopia Ghana Guatemala Guinea Haiti Indonesia Iran (Islamic Republic of) Jamaica Kazakhstan Kenya Kyrgyzstan Liberia Malawi Mali Mauritania Mozambique Myanmar Namibia Nepal Nigeria Pakistan Papua New Guinea Philippines Rwanda Senegal South Africa South Sudan Sudan Tajikistan Thailand Turkmenistan Uganda United Republic of Tanzania Uzbekistan Viet Nam Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Innovative patent-centric solutions that support detection and treatment Drug-Resistant TB: Specific modules developed that encompass patient-level data respectively on sensible Tb, multi-drug resistant Tb, patients receiving prophylaxy to INH, and person in contact with bacteriologically confirmed pulmonary TB patients. TB-HIV: Integration modules that track HIV co-infection |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | March 21, 2018 |
| Last updated: | March 21, 2018 |